The worldwide epidemiology of type 2 diabetes 324 mellitus--present and future perspectives, Nat Rev Endocrinol, vol.8, issue.4, pp.228-264, 2011. ,
Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies 328 with 4.4 million participants, Diabetes Res Clin Pract, vol.94, issue.3, pp.1513-1530, 2011. ,
Global 330 healthcare expenditure on diabetes for 2010 and 2030, Diabetes Res Clin Pract, vol.87, issue.3, pp.293-331, 2010. ,
Economic evaluation of lifestyle interventions for 333 preventing diabetes and cardiovascular diseases, Int J Environ Res Public Health, vol.7, issue.8, pp.3150-95, 2010. ,
335 Diabetes prevention and treatment strategies: are we doing enough? Diabetes Care, vol.36, pp.2714-2723, 2013. ,
, , p.338
Cohort Profile: Rationale and design of the fourth visit of the 339 STANISLAS cohort: a familial longitudinal population-based cohort from the Nancy region of France ,
, Int J Epidemiol, vol.47, issue.2, pp.395-395, 2018.
, , vol.342
Heritability of a resting heart rate in a 20-year follow-343 up family cohort with GWAS data: Insights from the STANISLAS cohort, Eur J Prev Cardiol, p.344, 2019. ,
, Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2019
, Diabetes Care, vol.42, p.10, 2019.
Homogeneous antibody-348 based proximity extension assays provide sensitive and specific detection of low-abundant proteins 349 in human blood, Nucleic Acids Res, vol.39, issue.15, p.11, 2011. ,
, , vol.351
Effects of 352 spironolactone on serum markers of fibrosis in people at high risk of developing heart failure: 353 rationale, design and baseline characteristics of a proof-of-concept, randomised, precision-medicine, 354 prevention trial. The Heart OMics in AGing (HOMAGE) trial, Eur J Heart Fail, vol.355, p.12, 2020. ,
, , vol.356
Expansion 357 of the Human Phenotype Ontology (HPO) knowledge base and resources, Nucleic Acids Res, vol.47, issue.D1, p.13, 2019. ,
DisGeNET: a comprehensive platform integrating 361 information on human disease-associated genes and variants, Nucleic Acids Res, vol.45, issue.D1, p.14, 2017. ,
, , vol.364
Population-wide weight loss and regain in relation to diabetes burden and 365 cardiovascular mortality in Cuba 1980-2010: repeated cross sectional surveys and ecological 366 comparison of secular trends, Bmj, vol.346, p.15, 2013. ,
Type 2 diabetes in indigenous Australian 368 children and adolescents, J Paediatr Child Health, vol.46, issue.9, p.16, 2010. ,
The 370 incidence, clinical features, and treatment of type 2 diabetes in children <15 yr in a population-based 371 cohort from Auckland, Pediatr Diabetes, vol.13, issue.4, p.17, 1995. ,
Global and societal implications of the diabetes 373 epidemic, Nature, vol.414, issue.6865, p.18, 2001. ,
Cardiovascular 375 risk factors in confirmed prediabetic individuals. Does the clock for coronary heart disease start 376 ticking before the onset of clinical diabetes?, Jama, vol.263, issue.21, p.19, 1990. ,
The reality of type 2 diabetes prevention. Diabetes Care, Prev Med, vol.37, issue.4, p.21, 2014. ,
, , p.381
10-year follow-up of diabetes 382 incidence and weight loss in the Diabetes Prevention Program Outcomes Study, Lancet, vol.374, issue.9702, p.22, 2009. ,
,
Reduction in the incidence of type 2 diabetes with lifestyle intervention or 386 metformin, N Engl J Med, vol.346, issue.6, p.23, 2002. ,
, , vol.388
Effect of weight loss with lifestyle 389 intervention on risk of diabetes, Diabetes Care, vol.29, issue.9, p.24, 2006. ,
, , vol.391
The 10-year cost-effectiveness of lifestyle intervention or metformin for diabetes 395 prevention: an intent-to-treat analysis of the DPP/DPPOS, Diabetes Care, vol.368, issue.9548, p.26, 2006. ,
IGFBP-4 and PAPP-A in normal physiology and disease, Growth Horm IGF Res, vol.397, p.27, 2018. ,
Insulin-like growth factors and their binding proteins: biological 399 actions, Endocr Rev, vol.16, issue.1, p.28, 1995. ,
, , p.401
Transgenic overexpression of pregnancy-associated plasma protein-A in murine 402 arterial smooth muscle accelerates atherosclerotic lesion development, Am J Physiol Heart Circ 403 Physiol, vol.299, issue.2, p.29, 2010. ,
, , p.405
Pregnancy-associated plasma protein-A (PAPP-406 A) in ovine, bovine, porcine, and equine ovarian follicles: involvement in IGF binding protein-4 407 proteolytic degradation and mRNA expression during follicular development, Endocrinology, vol.408, issue.12, p.30, 2001. ,
Pregnancy-associated 410 plasma protein-A accounts for the insulin-like growth factor (IGF)-binding protein-4 (IGFBP-4) 411 proteolytic activity in human pregnancy serum and enhances the mitogenic activity of IGF by 412 degrading IGFBP-4 in vitro, J Clin Endocrinol Metab, vol.86, issue.2, p.31, 2001. ,
, , p.414
Serum plasma pregnancy-associated protein A: a potential marker of echogenic carotid 415 atherosclerotic plaques in asymptomatic hyperlipidemic subjects at high cardiovascular risk ,
, Arterioscler Thromb Vasc Biol, vol.23, issue.1, p.32, 2003.
, , vol.418
419 Physiological parameters regulating circulating levels of the IGFBP-4/Stanniocalcin-2/PAPP-A axis, vol.75, pp.16-24, 2017. ,
, , p.422
The IGF system in patients with type 2 diabetes: 423 associations with markers of cardiovascular target organ damage, Eur J Endocrinol, vol.176, issue.5, p.34, 2017. ,
, , p.426
Pregnancy-associated plasma protein-a levels are related to glycemic 427 control but not to lipid profile or hemostatic parameters in type 2 diabetes. Diabetes Care, vol.30, p.35, 2007. ,
Elevated 430 pregnancy-associated plasma protein-a in sera from type 2 diabetic patients with 431 hypercholesterolemia: associations with carotid atherosclerosis and toe-brachial index, J Clin, p.432 ,
, , vol.89, p.36, 2004.
, , p.434
Mice deficient in PAPP-A show resistance to the development of diabetic nephropathy, J 435 Endocrinol, vol.219, issue.1, p.37, 2013. ,
Longevity 437 and age-related pathology of mice deficient in pregnancy-associated plasma protein-A, Biol Sci Med Sci, vol.438, issue.6, p.38, 2010. ,
The GH/IGF-1 axis in 440 ageing and longevity, Nat Rev Endocrinol, vol.2013, issue.6, p.39 ,
Assignment 442 of the human gene for pregnancy-associated plasma protein A (PAPPA) to 9q33.1 by fluorescence in 443 situ hybridization to mitotic and meiotic chromosomes, Cytogenet Cell Genet, vol.62, issue.4, p.40, 1993. ,
, , p.445
EPHB4 inhibition activates ER stress to promote immunogenic cell death of 446 prostate cancer cells, Cell Death Dis, vol.10, issue.11, p.41, 2019. ,
, , p.448
, Human Carboxylesterase, vol.2, p.449
, Induced Diacylglycerol Accumulation and Glucose Intolerance, Cell Rep, vol.18, issue.3, p.42, 2017.
The TNF Superfamily-2008, Cytokine Growth Factor Rev, vol.19, issue.3-4, p.43, 2008. ,
Emerging Roles of Vascular Cell 452 ,
, Adhesion Molecule-1 (VCAM-1) in Immunological Disorders and Cancer, Int J Mol Sci, vol.19, issue.4, p.44, 2018.
, , p.454
FGF21 Regulates Metabolism Through Adipose-455 Dependent and -Independent Mechanisms, Cell Metab, vol.25, issue.4, p.45, 2017. ,
Increased 457 serum/plasma fibroblast growth factor 21 in type 2 diabetes mellitus: a systematic review and meta-458 analysis, Postgrad Med J, vol.2019, p.46, 1121. ,
Relationship between family 460 history of type 2 diabetes and serum FGF21, Eur J Clin Invest, vol.47, issue.11, pp.853-859, 2017. ,